Comorbidity Burden of Patients with Parkinson’s Disease and Parkinsonism Between 2003 and 2012: A Multicentre, Nationwide, Retrospective Study in China
Xin Wang,Fan Zeng,Wang-Sheng Jin,Chi Zhu,Qing-Hua Wang,Xian-Le Bu,Hong-Bo Luo,Hai-Qiang Zou,Jie Pu,Zhong-He Zhou,Xiao-Ping Cui,Qing-Song Wang,Xiang-Qun Shi,Wei Han,Qiang Wu,Hui-Sheng Chen,Hang Lin,Li-Li Zhang,Meng Zhang,Yan Lian,Zhi-Qiang Xu,Hua-Dong Zhou,Tao Zhang,Yan-Jiang Wang
DOI: https://doi.org/10.1038/s41598-017-01795-0
IF: 4.6
2017-01-01
Scientific Reports
Abstract:Parkinson’s disease (PD) and Parkinsonism are common neurodegenerative disorders with continuously increasing prevalence, causing high global burdens. However, data concerning the comorbidity burden of patients with PD or Parkinsonism in China are lacking. To investigate the health condition and comorbidity burden, a total of 3367 PD and 823 Parkinsonism patients were included from seven tertiary hospitals in seven cities across China from 2003 to 2012. Their comorbidity burden was collected and quantified by the Elixhauser Comorbidity Index (ECI) and Charlson Comorbidity Index (CCI). The comorbidity spectra differed between PD and Parkinsonism patients. Compared with PD patients, Parkinsonism patients were older (69.8 ± 11.5 vs. 67.9 ± 11.4, P < 0.001); had a higher comorbidity burden, including ECI (1.1 ± 1.2 vs. 1.0 ± 1.2, P < 0.001) and CCI (1.3 ± 1.6 vs. 1.1 ± 1.5, P < 0.001); and had higher hospitalization expenses. The ECI (1.1 ± 1.3 vs. 0.9 ± 1.1, P < 0.001) and CCI (1.3 ± 1.6 vs. 0.9 ± 1.2, P < 0.001) were higher in males than in females. The average length of stay and daily hospitalization expenses increased with age, as did ECI and CCI. This is the first study to report the disease burden of Chinese PD and Parkinsonism patients. It provides useful information to better understand their health status, and to raise the awareness of clinicians for providing better health care.